Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A

Biochemistry
Shouichi Higashi, Kaoru Miyazaki

Abstract

In various mammalian cell lines, beta-amyloid precursor protein (APP) is proteolytically processed to release its NH(2)-terminal extracellular domain as a soluble APP (sAPP) that contains the inhibitor domain against gelatinase A. To investigate roles of sAPP in the regulation of gelatinase A activity, we examined the correlation between the activation of progelatinase A and processing of APP. We found that stimulation of HT1080 fibrosarcoma cells with concanavalin A led to an activation of endogenous progelatinase A and to a novel processing of APP, which releases a COOH-terminally truncated form of sAPP (sAPPtrc) into the culture medium. Reverse zymographic analysis showed that sAPPtrc lacked an inhibitory activity against gelatinase A. Analyses of production of sAPPtrc in the presence of various metalloproteinase inhibitors showed that membrane type 1 matrix metalloproteinase (MT1-MMP), an activator of progelatinase A, is most likely responsible for the production of sAPPtrc. When the concanavalin A-stimulated HT1080 cells were cultured in the condition that inhibited MT1-MMP activity, sAPP and APP were associated with the extracellular matrix deposited by the cells, whereas these gelatinase A inhibitors in the matrix were d...Continue Reading

References

Feb 28, 1991·Biochemical and Biophysical Research Communications·W E Van NostrandD D Cunningham
Jan 1, 1993·Annual Review of Cell Biology·W G Stetler-StevensonL A Liotta
May 10, 1996·The Journal of Biological Chemistry·J ArribasJ Massagué

❮ Previous
Next ❯

Citations

May 9, 2006·Cancer Metastasis Reviews·Alex Y Strongin
Dec 4, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Margaret W NdinguriGregg B Fields
Apr 23, 2005·Glia·Lee Anna CunninghamGary A Rosenberg
Nov 4, 2010·Journal of Neurochemistry·Stefan F Lichtenthaler
Mar 8, 2005·The Journal of Biological Chemistry·Christine A F von ArnimBradley T Hyman
Mar 29, 2006·Journal of Biochemistry·Munirah AhmadHiroshi Sato
Jun 15, 2007·Critical Reviews in Biochemistry and Molecular Biology·Bénédicte CauweGhislain Opdenakker
Oct 15, 2019·Frontiers in Aging Neuroscience·Laura García-GonzálezSantiago Rivera
Jun 6, 2019·Cellular and Molecular Life Sciences : CMLS·Sameeksha ChopraAntoine Dufour
Jun 15, 2019·Cellular and Molecular Life Sciences : CMLS·Santiago RiveraKévin Baranger
Nov 30, 2011·Journal of Neurochemistry·Valérie Vingtdeux, Philippe Marambaud
Oct 3, 2017·Frontiers in Molecular Neuroscience·Xin WangWeihong Song
Oct 29, 2008·The Journal of Biological Chemistry·Shouichi HigashiKaoru Miyazaki
Dec 8, 2020·Oxidative Medicine and Cellular Longevity·Patricia LlorenteMaria J Bullido
Mar 2, 2021·Journal of Alzheimer's Disease : JAD·Guimei ZhangLi Sun
Jul 10, 2021·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Natalia MorachoCristina Sánchez-Camacho
May 28, 2020·Journal of Medicinal Chemistry·Pauline ZipfelPatrick Dallemagne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.